Need help?

Specialty Pharmaceuticals Businesses for Sale and Investment in Visakhapatnam

Showing 1 - 2 of 2 Specialty Pharmaceuticals Businesses for Sale and Investment in Visakhapatnam. Buy or Invest in a Specialty Pharmaceutical Business. Listed by Direct Business Owners & Business Brokers.
Filters
  • Specialty Pharmaceuticals

  • Visakhapatnam

 

Specialty Pharmaceuticals Company for Sale in Visakhapatnam, India

Acquire an NPA turnkey pharma API manufacturer with over 40 domestic and international clients.
Established in Vizag JN Pharma City, this API manufacturer operates in a prime location known for its robust infrastructure in the pharmaceuticals industry, catering to domestic and international markets. - Specializes in high-demand active pharmaceutical ingredients (APIs) across various therapeutic categories including oncology, diabetes, cardiovascular, and anti-allergic drugs, appealing to top pharmaceutical formulators both in India and abroad. - Boasts a strong international presence with export relationships across Japan, UK, France, and Bangladesh, indicating its credibility and demand in diverse markets. - Serves a substantial client base of 40 to 50, highlighting a stable and expanding market reach with an emphasis on both domestic and export clientele. - The facility has an advanced production capacity of 98 kiloliters, with the potential to scale operations to 250 kiloliters, underscoring its readiness for increased demand and large-scale API manufacturing. - Holds ISO 9000 certification, underscoring its commitment to quality management systems and ensuring compliance with internationally recognized standards. - The business is incorporated and features USFDA approval for one of its products, reinforcing its competitive position and enabling access to the lucrative US pharmaceuticals market. - The operations have been halted due to non-payment of a working capital loan, and the bank has seized the assets due to NPA.
Acquire an NPA turnkey pharma API manufacturer with over 40 domestic and international clients.
7.6   Visakhapatnam
Run Rate Sales
Nil
EBITDA Margin
Nil
Business for Sale
USD 8.1 Mn
Contact Business

Specialty Pharmaceuticals Company Investment Opportunity in Visakhapatnam, India

New biopharmaceutical company with a primary focus on plasma fractionation to manufacture therapeutic plasma proteins.
● Our business has already obtained DCGI approval to manufacture the following proteins in the R&D Unit for the purpose of research and analysis. ● Our R&D unit is set up in 2,000 sq ft space in MN iHub, GenomeValley, Turkapally, Hyderabad with 3 state-of-the-art designated lab spaces for process development, analytical R&D and quality control with a total of 25 staff members. ● Our protein samples are already been extracted and stability studies are being done. ● 150,000 sq ft manufacturing facility is under contraction and will be completed soon. ● By the time the business starts operations, we will have 200 employees. ● Founders are based in the US.
6.4   Visakhapatnam
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 4 Mn for 10%
Contact Business
List your business on SMERGERS.
Get visibility from 110,000+ member network of Businesses, Investors, Acquirers, Lenders and Advisors from 900+ Industries and 170+ Countries
Create Business Profile

Specialty Pharmaceuticals Company Investment Opportunity in Visakhapatnam, India

New biopharmaceutical company with a primary focus on plasma fractionation to manufacture therapeutic plasma proteins.
● Our business has already obtained DCGI approval to manufacture the following proteins in the R&D Unit for the purpose of research and analysis. ● Our R&D unit is set up in 2,000 sq ft space in MN iHub, GenomeValley, Turkapally, Hyderabad with 3 state-of-the-art designated lab spaces for process development, analytical R&D and quality control with a total of 25 staff members. ● Our protein samples are already been extracted and stability studies are being done. ● 150,000 sq ft manufacturing facility is under contraction and will be completed soon. ● By the time the business starts operations, we will have 200 employees. ● Founders are based in the US.
6.4   Visakhapatnam
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 4 Mn for 10%
Contact Business
Frequently
Asked
Questions
  • How many specialty pharmaceuticals businesses for sale and investment in Visakhapatnam are listed on SMERGERS?
    There are 2 active and verified specialty pharmaceuticals businesses for sale and investment in Visakhapatnam listed on SMERGERS as of 25 July 2025.
  • What level of due diligence does SMERGERS conduct on the businesses/member?

    SMERGERS scrutinizes all profiles and only features a select group of businesses, investors, advisors that meet a basic requirement. When required, certain members may have submitted some form of proof …read more

  • How active are the business profiles listed on SMERGERS?

    We regularly filter out businesses which are inactive or have already closed a transaction. Typically, if the business is actively looking to sell/raise capital, the status is shown in green.

  • How can I be sure about privacy and confidentiality?

    We understand the level of confidentiality required in strategic transactions and we strive to provide a safe and secure experience for our members. Please review our privacy policy. We …read more

  • How can I contact a business listed on SMERGERS?

    You need to be logged in before you connect with a business. Click here to register and message the business If you are already logged in, please use the contact …read more

  • Should you buy an existing business or start a business from scratch?

    Buying an existing business is generally an easier way to start a business with an immediate head start. It saves valuable time and administrative efforts, considering starting from scratch is …read more

  • How successful has SMERGERS been in helping its users successfully close a deal?

    SMERGERS is a discovery and matchmaking platform with a global reach. It helps in connecting Businesses, Investors, Acquirers, Lenders, M&A Advisors and Boutique Investment Banks across locations, industries and transactions. …read more

  • Show more